Clinical Characteristics and Outcomes in Patients With KRAS G12C Mutated Non-Small Cell Lung Cancer

被引：0
|
作者：
Pellini, B. [1 ]
Ganesan, V. [2 ]
Wan, F. [3 ]
Sankararaman, S. [4 ]
Manyanont, S. [4 ]
Akhave, N. [5 ]
Baggstrom, M. [4 ]
Ward, J. [4 ]
Waqar, S. [4 ]
Morgensztern, D. [4 ]
Govindan, R. [6 ]
Devarakonda, S. [4 ]
机构：
[1] H Lee Moffitt Canc Ctr & Res Inst, Dept Thorac Oncol, Tampa, FL USA
[2] Univ Missouri, Sch Med, Kansas City, MO 64108 USA
[3] Washington Univ, Sch Med, Div Publ Hlth Sci, St Louis, MO 14263 USA
[4] Washington Univ, Sch Med, Div Oncol, St Louis, MO USA
[5] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[6] Siteman Canc Ctr, St Louis, MO USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2021年 / 16卷 / 03期
关键词：
Non-small cell lung cancer; KRAS G12C mutation; KRAS-mutant NSCLC;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
FP07.13
引用
收藏
页码：S209 / S210
页数：2
相关论文
共 50 条
  • [31] Correction to: Sotorasib: A Review in KRAS G12C Mutation-Positive Non-small Cell Lung Cancer
    Arnold Lee
    Targeted Oncology, 2023, 18 : 177 - 177
  • [32] Durability of Clinical Benefit and Biomarkers in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC) Treated with Sotorasib, a KRAS(G12C) Inhibitor
    Hong, D. S.
    Bang, Y. -J.
    Barlesi, F.
    Durm, G.
    Falchook, G.
    Govindan, R.
    Dy, G.
    Park, K.
    Strickler, J.
    Burns, T.
    Kim, J.
    Ang, A.
    Lipford, J. R.
    Ngarmchamnanrith, G.
    Anderson, A.
    Li, B. T.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (01) : S28 - S29
  • [33] Survival of patients with KRAS G12C mutated stage IV non-small cell lung cancer with and without brain metastases treated with immune checkpoint inhibitors
    Noordhof, Anneloes L.
    Swart, Esther M.
    Damhuis, Ronald A. M.
    Kunst, Peter W. A.
    De Ruysscher, Dirk K. M.
    Hendriks, Lizza E. L.
    Van Geffen, Wouter H.
    Aarts, Mieke J.
    EUROPEAN RESPIRATORY JOURNAL, 2023, 62
  • [34] KRAS G12C mutation as a poor prognostic marker of pemetrexed treatment in non-small cell lung cancer
    Park, Sehhoon
    Kim, Ji-Yeon
    Lee, Se-Hoon
    Suh, Beomseok
    Keam, Bhumsuk
    Kim, Tae Min
    Kim, Dong-Wan
    Heo, Dae Seog
    KOREAN JOURNAL OF INTERNAL MEDICINE, 2017, 32 (03): : 514 - 522
  • [35] GTPase KRAS (G12C mutant) inhibitor Treatment of non-small cell lung cancer Treatment of colorectal cancer
    Shao, Shi-yun
    Rong, Wen-qing
    Talukder, Salehikram
    Jia, Ru
    Chen, Zhe-Sheng
    DRUGS OF THE FUTURE, 2022, 47 (11) : 783 - 795
  • [36] Efficacy of JS']JSI-1187 or VIC-1911 in combination with KRAS G12C inhibitors for the treatment of KRAS G12C-mutated non-small cell lung cancer and colorectal cancer
    Zhang, Lei
    Li, Ao
    Jian, Shanzhong
    Du, Chengyi
    Zhu, Wan
    Tao, Yue
    Wang, Meiwei
    Xu, Wen
    Hao, Wenshan
    Paradiso, Linda
    Myers, Thomas
    Koya, Keizo
    Zhang, Jintao
    CANCER RESEARCH, 2023, 83 (07)
  • [37] Early Changes in Circulating Cell-Free KRAS G12C Predict Response to Adagrasib in KRAS Mutant Non-Small Cell Lung Cancer Patients
    Paweletz, Cloud P.
    Heavey, Grace A.
    Kuang, Yanan
    Durlacher, Emily
    Kheoh, Thian
    Chao, Richard C.
    Spira, Alexander I.
    Leventakos, Konstantinos
    Johnson, Melissa L.
    Ou, Sai-Hong Ignatius
    Riely, Gregory J.
    Anderes, Kenna
    Yang, Wenjing
    Christensen, James G.
    Janne, Pasi A.
    CLINICAL CANCER RESEARCH, 2023, 29 (16) : 3074 - 3080
  • [38] Targeting WEE1 to improve the therapy of KRAS G12C mutant non-small cell lung cancer
    Yamamoto, Gaku
    Tanaka, Kosuke
    Kamata, Ryo
    Mori, Shunta
    Liu, Jie
    Yamauchi, Toyohiro
    Sakae, Yuta
    Ohashi, Akihiro
    Kobayashi, Susumu S.
    CANCER RESEARCH, 2023, 83 (07)
  • [39] Characteristics and treatment sequences of patients (pts) with KRAS G12C, other KRAS and non-KRAS advanced or metastatic (AM) non-small cell lung cancer (NSCLC) in the French ESME cohort
    Girard, N.
    Perol, M.
    Debieuvre, D.
    Bosquet, L.
    Veillard, C.
    Caillon, M.
    Tzala, L.
    Desamericq, G.
    Valette, C. Audigier
    ANNALS OF ONCOLOGY, 2023, 34
  • [40] Clinicopathologic characteristics and outcomes for patients with KRAS G12D-mutant non-small cell lung cancer (NSCLC).
    Cooper, Alissa Jamie
    Muzikansky, Alona
    Lennerz, Jochen K.
    Mino-Kenudson, Mari
    Hung, Yin P.
    Piotrowska, Zofia
    Dagogo-Jack, Ibiayi
    Sequist, Lecia V.
    Lin, Jessica Jiyeong
    Gainor, Justin F.
    Heist, Rebecca Suk
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
12345